Utility of 18FDOPA PET/MRI for Focal Hyperinsulinism

Abroad (travel likely)RecruitingPHASE2

Conditions

Hyperinsulinism

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Washington University, St Louis, Missouri, United States
Contact: Study coordinator (Ana M Arbelaez, MD) · aarbelaez@wustl.edu · 314-454-6051
Maria R Ponisio, MD (Sub-investigator)

Study leads

Ana Maria Arbelaez, MD, MSCI
Principal Investigator
Washington University School of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy

Breast Cancer · Hyperinsulinism · HER2-negative Breast Cancer

Abroad (travel likely)RecruitingPHASE1

New Haven, United States

18F-DOPA II - PET Imaging Optimization

Congenital Hyperinsulinism · Neuroblastoma · Parkinson Disease

Abroad (travel likely)RecruitingPHASE3

Edmonton, Canada

Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars

Scars · Insulin

Abroad (travel likely)Recruiting

Alexandria, Egypt

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Congenital Hyperinsulinism · Insulinoma

Abroad (travel likely)RecruitingPHASE1

Fort Worth, United States